Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
amisulpride | dopamine d2 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Emotions[MeSHID:D004644] Disease[MeSHID:D004194] Hallucinations[MeSHID:D006212] Delusions[MeSHID:D003702] Vomiting[MeSHID:D014839] Neoplasm Metastasis[MeSHID:D009362] Hostility[MeSHID:D006791] Mood Disorders[MeSHID:D019964] Affect (mental function)[MeSHID:D000339] Postoperative Nausea[MeSHID:D020250] Behavior[MeSHID:D001519] Syndrome[MeSHID:D013577] Malnutrition[MeSHID:D044342] Thinking function[MeSHID:D013850] Chronic disease[MeSHID:D002908] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
0.36 | approved,investigational | antagonist |
amisulpride | dopamine d3 receptor | small molecule | NA | drugbank , DGIDB | Emotions[MeSHID:D004644] Disease[MeSHID:D004194] Hallucinations[MeSHID:D006212] Delusions[MeSHID:D003702] Vomiting[MeSHID:D014839] Neoplasm Metastasis[MeSHID:D009362] Hostility[MeSHID:D006791] Mood Disorders[MeSHID:D019964] Affect (mental function)[MeSHID:D000339] Postoperative Nausea[MeSHID:D020250] Behavior[MeSHID:D001519] Syndrome[MeSHID:D013577] Malnutrition[MeSHID:D044342] Thinking function[MeSHID:D013850] Chronic disease[MeSHID:D002908] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
0.41 | approved,investigational | antagonist |
amisulpride | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank | Emotions[MeSHID:D004644] Disease[MeSHID:D004194] Hallucinations[MeSHID:D006212] Delusions[MeSHID:D003702] Vomiting[MeSHID:D014839] Neoplasm Metastasis[MeSHID:D009362] Hostility[MeSHID:D006791] Mood Disorders[MeSHID:D019964] Affect (mental function)[MeSHID:D000339] Postoperative Nausea[MeSHID:D020250] Behavior[MeSHID:D001519] Syndrome[MeSHID:D013577] Malnutrition[MeSHID:D044342] Thinking function[MeSHID:D013850] Chronic disease[MeSHID:D002908] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | antagonist |
amisulpride | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank | Emotions[MeSHID:D004644] Disease[MeSHID:D004194] Hallucinations[MeSHID:D006212] Delusions[MeSHID:D003702] Vomiting[MeSHID:D014839] Neoplasm Metastasis[MeSHID:D009362] Hostility[MeSHID:D006791] Mood Disorders[MeSHID:D019964] Affect (mental function)[MeSHID:D000339] Postoperative Nausea[MeSHID:D020250] Behavior[MeSHID:D001519] Syndrome[MeSHID:D013577] Malnutrition[MeSHID:D044342] Thinking function[MeSHID:D013850] Chronic disease[MeSHID:D002908] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | antagonist |
amisulpride | delta-type opioid receptor | small molecule | NA | drugbank | Emotions[MeSHID:D004644] Disease[MeSHID:D004194] Hallucinations[MeSHID:D006212] Delusions[MeSHID:D003702] Vomiting[MeSHID:D014839] Neoplasm Metastasis[MeSHID:D009362] Hostility[MeSHID:D006791] Mood Disorders[MeSHID:D019964] Affect (mental function)[MeSHID:D000339] Postoperative Nausea[MeSHID:D020250] Behavior[MeSHID:D001519] Syndrome[MeSHID:D013577] Malnutrition[MeSHID:D044342] Thinking function[MeSHID:D013850] Chronic disease[MeSHID:D002908] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | agonist |
amisulpride | kappa-type opioid receptor | small molecule | NA | drugbank | Emotions[MeSHID:D004644] Disease[MeSHID:D004194] Hallucinations[MeSHID:D006212] Delusions[MeSHID:D003702] Vomiting[MeSHID:D014839] Neoplasm Metastasis[MeSHID:D009362] Hostility[MeSHID:D006791] Mood Disorders[MeSHID:D019964] Affect (mental function)[MeSHID:D000339] Postoperative Nausea[MeSHID:D020250] Behavior[MeSHID:D001519] Syndrome[MeSHID:D013577] Malnutrition[MeSHID:D044342] Thinking function[MeSHID:D013850] Chronic disease[MeSHID:D002908] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | agonist |
amisulpride | mu-type opioid receptor | small molecule | NA | drugbank | Emotions[MeSHID:D004644] Disease[MeSHID:D004194] Hallucinations[MeSHID:D006212] Delusions[MeSHID:D003702] Vomiting[MeSHID:D014839] Neoplasm Metastasis[MeSHID:D009362] Hostility[MeSHID:D006791] Mood Disorders[MeSHID:D019964] Affect (mental function)[MeSHID:D000339] Postoperative Nausea[MeSHID:D020250] Behavior[MeSHID:D001519] Syndrome[MeSHID:D013577] Malnutrition[MeSHID:D044342] Thinking function[MeSHID:D013850] Chronic disease[MeSHID:D002908] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] |
NA | approved,investigational | agonist |
click here to return to the previous page |